Navigation Links
GRANISOL™ (Granisetron) Oral Solution Eligible for Medicaid Reimbursement
Date:4/13/2011

ing hospitalization. PediatRx trades on the OTCBB under the ticker symbol PEDX.

Forward Looking Statements

This press release contains forward-looking statements.  Forward-looking statements are projections of events, revenues, income, future economics, research, development, reformulation, product performance or management's plans and objectives for future operations.  In some cases you can identify forward-looking statements by the use of terminology such as "may", "should", "anticipates", "believes", "expects", "intends", "forecasts", "plans", "future", "strategy", or words of similar meaning.  Forward-looking statements in this press release include those concerning expected growth in prescription drug coverage under Medicaid.  While these forward-looking statements and any assumptions upon which they are based are made in good faith and reflect current judgment regarding the direction of the business operations of PediatRx, actual results will almost always vary, sometimes materially, from any estimates, predictions, projections, assumptions or other future performance suggested in this press release.  These statements are predictions and involve known and unknown risks, uncertainties and other factors, including the risk that PediatRx cannot execute its business plan for lack of capital or other resources, distribution, partnering or licensing/acquisition opportunities, as well as the risks described in the periodic disclosure documents filed on EDGAR by PediatRx, copies of which are also available on the company's website.  Any of these risks could cause PediatRx or its industry's actual results, levels of activity, performance or achievements to be materially different from those expressed or implied by the forward-looking statements in this press release.  Except as required by applicable law, including the securities laws of the United States, PediatRx does not intend to update any of the forwa
'/>"/>

SOURCE PediatRx, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. ePharmaSolutions Launches New Application to Streamline Single Sign-On and User Account Provisioning for Sponsors Using Multiple Clinical Trial Technologies
2. UC San Diego chemists produce first high-resolution RNA nano square
3. delSECUR CORPORATION Announces Its Dissolution; and the Distribution of Its Asset to Its Lenders and Shareholders of the Corporation
4. Perceptive Informatics Introduces DataLabs® 5.0 EDC Solution, Unlocking New Clinical Trial Process Efficiencies
5. Announcing ValGenesis On-Demand SaaS Solution
6. Finesse Solutions Introduces New T700 cGMP Upstream Processing Platform Featuring G3 Hardware and Fully Integrated Single-Use Sensors
7. Finesse Solutions Showcases SmartBag with Fully Integrated Single-Use pH and pO2 Sensors for Rocker Bioreactors at Interphex 2011
8. M-3 Information, a Leader in Expert Behavioral Health Solutions, Launches M3Clinician.com
9. D3 Oncology Solutions Now Includes Via Oncology Pathways for Medical Oncology
10. 3-D nanoparticle in atomic resolution
11. A nano-solution to global water problem: Nanomembranes could filter bacteria
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2014)... , Nov. 24, 2014  Spherix Incorporated (Nasdaq: ... committed to the fostering and monetization of intellectual ... VTech Telecommunications Ltd.,  Case No. 3:13-cv-03494-M and  Spherix ... 3:13-cv-03496-M, both in the United States District Court ... . On November 21, ...
(Date:11/22/2014)... (PRWEB) November 21, 2014 Two new educational ... what comes next for ALS research and how the pharmaceutical ... After the Ice Bucket Challenge: Where Does the ALS Money ... Tuesday, 2 December 2014, Time: 1:30pm ET, Register ... expert speaker Dr. Merit Cudkowicz, Julianne Dorn Professor of Neurology ...
(Date:11/22/2014)... Colo. (PRWEB) November 21, 2014 ... proprietary cloud based analytics and scientific testing methodologies relating ... commitment for a $750,000 line of credit from an ... extremely pleased to have secured this commitment from one ... Executive Officer of CannLabs. “This capital will help accelerate ...
(Date:11/22/2014)... The “Chiral Chromatography Columns Market by ... Glass, Plastic), by Application [GC, LC (HPLC, UHPLC, ... 2018” analyses and studies the major market drivers, ... Asia, and Rest of the World. , Browse ... through 135 pages and in-depth TOC on “Chiral ...
Breaking Biology Technology:Markman Hearing Held as Scheduled in VTech and Uniden Cases 2DrugDev Webinars in December to Explore What Comes Next for ALS Research and How We Can Make Life Easier for Clinical Sites 2CannLabs Secures $750,000 Line Of Credit 2Chiral Chromatography Columns Market worth $87.8 Million by 2018 - New Research Report by MarketsandMarkets 2Chiral Chromatography Columns Market worth $87.8 Million by 2018 - New Research Report by MarketsandMarkets 3Chiral Chromatography Columns Market worth $87.8 Million by 2018 - New Research Report by MarketsandMarkets 4Chiral Chromatography Columns Market worth $87.8 Million by 2018 - New Research Report by MarketsandMarkets 5
... Inc. (Nasdaq: NVAX ) today announced that it ... press release to be issued after 8:00 a.m. Eastern Time ... investor conference call to discuss its financial results at 10:00 ... will be hosted by Novavax President and Chief Executive Officer ...
... May 4 The Arcas Group, a ... Stefan Terwindt, MBA as Executive Vice President. He will ... Terwindt previously served as President of Imedex, Inc."Stefan is ... and skills to our company," said Founder and President ...
... & Company, LLC, a Boston-based life science investment bank, ... has joined the firm as senior advisor. In ... on internal and client-related activities including private equity placements ... focus on medical device transactions. "We are thrilled ...
Cached Biology Technology:Novavax Announces Release Date of 2009 First Quarter, Financial Results and Investor Conference Call 2The Arcas Group Appoints Executive Vice President 2Venture Capital Veteran John Brooks Joins Life Science Investment Bank Johnston Blakely & Company 2
(Date:11/4/2014)... 2014) – A majority of Madagascar,s 101 species of ... serious consequences for the rainforests they call home. A ... impacts lemurs can have on rainforest tree populations, which ... have on the region,s rich biodiversity. , A large ... by lemurs. Lemurs in turn disperse the seeds ...
(Date:11/3/2014)... Center study published in this month,s ... the activity of a recently discovered communication molecule of ... has been known to limit inflammation and the current ... IL-37 inhibits the ability of the immune system to ... that underlies IL-37,s effect on the immune system now ...
(Date:11/2/2014)... In this month,s issue of Physics World , ... bridging the "valley of death" to take their innovations ... argues that the gruelling challenge facing all start-up companies ... harder for physicists because of two main factors: physics-based ... and they often turn out to be a lot ...
Breaking Biology News(10 mins):Gardeners of Madagascar rainforest at risk 2Gardeners of Madagascar rainforest at risk 3PNAS: From HIV to cancer, IL-37 regulates immune system 2The 'valley of death' facing physics start-ups 2
... developed at the Hebrew University of Jerusalem that is ... led to approval by the U.S. Food and Drug ... cardiac surgery patients. The product is the ... biodegradable polymers for the prevention of post-surgical adhesions. SyntheMed ...
... available in German . , Helsinki/Leipzig. ... trading, will only be successful if they are coherently ... issues, says a report published today by the Partnership ... from seven of the biggest European environmental research institutes. ...
... Both plant and human diseases that can travel ... more rapidly than has been understood, according to a ... only for some human diseases but also a new ... done by scientists at Oregon State University and other ...
Cached Biology News:Hebrew University professor's work leads to FDA approval for product 2Climate change aims need to be better integrated 2New wheat disease could spread faster than expected 2New wheat disease could spread faster than expected 3